Skip to main content
Erschienen in: Supportive Care in Cancer 5/2020

30.08.2019 | Original Article

Is the prognostic nutritional index a prognostic and predictive factor in metastatic non-small cell lung cancer patients treated with first-line chemotherapy?

verfasst von: Yakup Bozkaya, Osman Köstek, Abdullah Sakin, Deniz Tataroğlu Özyükseler, Teoman Şakalar, İbrahim Çil

Erschienen in: Supportive Care in Cancer | Ausgabe 5/2020

Einloggen, um Zugang zu erhalten

Abstract

Purpose

We aimed to assess the prognostic and predictive significance of pretreatment Onodera’s prognostic nutritional index (OPNI) in metastatic non-small cell lung cancer patients (NSCLC) treated with first-line chemotherapy.

Materials and methods

Patients with metastatic NSCLC who attended five different medical oncology clinics between December 2008 and January 2018 were retrospectively analyzed. The optimal cut-off point for OPNI was performed by a receiver operating characteristic (ROC) curve analysis. Patients were assigned to either the low OPNI group or high OPNI group.

Results

A total of 333 patients were included in the study. Significant differences between the low and high OPNI groups were found regarding the rates of response to chemotherapy, sex, and hemoglobin level (p < 0.05). The patients in high OPNI group had a longer overall survival (OS) (15.3 vs. 10.6 months, p < 0.001) and progression-free survival (PFS) (6.7 vs. 5.3 months, p < 0.001) compared to the patients in low OPNI group. A multivariate analysis using Cox regression model revealed that a high OPNI score was an independent prognostic factor of OS (HR = 1.535, p = 0.002) and PFS (HR = 1.336, p = 0.014), but failed to demonstrate a statistical significance of pretreatment OPNI scores in predicting treatment response (p = 0.56).

Conclusions

Pretreatment OPNI is an independent prognostic factor for OS and PFS in metastatic NSCLC patients treated with first-line chemotherapy. Thus, it may be used as easily calculated and low-cost prognostic tool in the routine clinical practice in this patient group.
Literatur
1.
Zurück zum Zitat Jemal A, Bray F, Center MM et al (2011) Global cancer statistics. CA Cancer J Clin 61:69–90CrossRef Jemal A, Bray F, Center MM et al (2011) Global cancer statistics. CA Cancer J Clin 61:69–90CrossRef
2.
Zurück zum Zitat Ben Amar J, Ben Safta B, Zaibi H, Dhahri B, Baccar MA, Azzabi S (2016) Prognostic factors of advanced stage non-small-cell lung cancer. Tunis Med 94:360–367PubMed Ben Amar J, Ben Safta B, Zaibi H, Dhahri B, Baccar MA, Azzabi S (2016) Prognostic factors of advanced stage non-small-cell lung cancer. Tunis Med 94:360–367PubMed
3.
Zurück zum Zitat Hu Y, Shen J, Liu R, Feng ZM, Zhang CN, Ling L, Chen LB (2018) Prognostic value of pretreatment prognostic nutritional index in non-small cell lung cancer: a systematic review and meta-analysis. Int J Biol Markers 33(4):372–378CrossRef Hu Y, Shen J, Liu R, Feng ZM, Zhang CN, Ling L, Chen LB (2018) Prognostic value of pretreatment prognostic nutritional index in non-small cell lung cancer: a systematic review and meta-analysis. Int J Biol Markers 33(4):372–378CrossRef
4.
Zurück zum Zitat Sachlova M, Majek O, Tucek S (2014) Prognostic value of scores based on malnutrition or systemic inflammatory response in patients with metastatic or recurrent gastric cancer. Nutr Cancer 66:1362–1370CrossRef Sachlova M, Majek O, Tucek S (2014) Prognostic value of scores based on malnutrition or systemic inflammatory response in patients with metastatic or recurrent gastric cancer. Nutr Cancer 66:1362–1370CrossRef
5.
Zurück zum Zitat Santarpia L, Contaldo F, Pasanisi F (2011) Nutritional screening and early treatment of malnutrition in cancer patients. J Cachexia Sarcopenia Muscle 2:27–35CrossRef Santarpia L, Contaldo F, Pasanisi F (2011) Nutritional screening and early treatment of malnutrition in cancer patients. J Cachexia Sarcopenia Muscle 2:27–35CrossRef
6.
Zurück zum Zitat Capra S, Ferguson M, Ried K (2001) Cancer: impact of nutrition intervention outcome--nutrition issues for patients. Nutrition 17:769–772CrossRef Capra S, Ferguson M, Ried K (2001) Cancer: impact of nutrition intervention outcome--nutrition issues for patients. Nutrition 17:769–772CrossRef
7.
Zurück zum Zitat Onodera T, Goseki N, Kosaki G (1984) Prognostic nutritional index in gastrointestinal surgery of malnourished cancer patients. Nihon Geka Gakkai Zasshi 85:1001–1005PubMed Onodera T, Goseki N, Kosaki G (1984) Prognostic nutritional index in gastrointestinal surgery of malnourished cancer patients. Nihon Geka Gakkai Zasshi 85:1001–1005PubMed
8.
Zurück zum Zitat Ikeya T, Shibutani M, Maeda K, Sugano K, Nagahara H, Ohtani H, Hirakawa K (2015) Maintenance of the nutritional prognostic index predicts survival in patients with unresectable metastatic colorectal cancer. J Cancer Res Clin Oncol 141:307–313CrossRef Ikeya T, Shibutani M, Maeda K, Sugano K, Nagahara H, Ohtani H, Hirakawa K (2015) Maintenance of the nutritional prognostic index predicts survival in patients with unresectable metastatic colorectal cancer. J Cancer Res Clin Oncol 141:307–313CrossRef
9.
Zurück zum Zitat Yao ZH, Tian GY, Wan YY, Kang YM, Guo HS, Liu QH, Lin DJ (2013) Prognostic nutritional index predicts outcomes of malignant pleural mesothelioma. J Cancer Res Clin Oncol 139:2117–2123CrossRef Yao ZH, Tian GY, Wan YY, Kang YM, Guo HS, Liu QH, Lin DJ (2013) Prognostic nutritional index predicts outcomes of malignant pleural mesothelioma. J Cancer Res Clin Oncol 139:2117–2123CrossRef
10.
Zurück zum Zitat Pinato DJ, North BV, Sharma R (2012) A novel, externally validated inflammation-based prognostic algorithm in hepatocellular carcinoma: the prognostic nutritional index (PNI). Br J Cancer 106:1439–1445CrossRef Pinato DJ, North BV, Sharma R (2012) A novel, externally validated inflammation-based prognostic algorithm in hepatocellular carcinoma: the prognostic nutritional index (PNI). Br J Cancer 106:1439–1445CrossRef
11.
Zurück zum Zitat Wang DS, Luo HY, Qiu MZ, Wang ZQ, Zhang DS, Wang FH, Li YH, Xu RH (2012) Comparison of the prognostic values of various inflammation based factors in patients with pancreatic cancer. Med Oncol 29:3092–3100CrossRef Wang DS, Luo HY, Qiu MZ, Wang ZQ, Zhang DS, Wang FH, Li YH, Xu RH (2012) Comparison of the prognostic values of various inflammation based factors in patients with pancreatic cancer. Med Oncol 29:3092–3100CrossRef
12.
Zurück zum Zitat Qiu C, Qu X, Shen H, Zheng C, Zhu L, Meng L, du J (2015) Evaluation of prognostic nutritional index in patients undergoing radical surgery with nonsmall cell lung Cancer. Nutr Cancer 67:741–747CrossRef Qiu C, Qu X, Shen H, Zheng C, Zhu L, Meng L, du J (2015) Evaluation of prognostic nutritional index in patients undergoing radical surgery with nonsmall cell lung Cancer. Nutr Cancer 67:741–747CrossRef
13.
Zurück zum Zitat Migita K, Takayama T, Saeki K, Matsumoto S, Wakatsuki K, Enomoto K, Tanaka T, Ito M, Kurumatani N, Nakajima Y (2013) The prognostic nutritional index predicts long-term outcomes of gastric cancer patients independent of tumor stage. Ann Surg Oncol 20:2647–2654CrossRef Migita K, Takayama T, Saeki K, Matsumoto S, Wakatsuki K, Enomoto K, Tanaka T, Ito M, Kurumatani N, Nakajima Y (2013) The prognostic nutritional index predicts long-term outcomes of gastric cancer patients independent of tumor stage. Ann Surg Oncol 20:2647–2654CrossRef
14.
Zurück zum Zitat Shimizu K, Okita R, Saisho S, Maeda A, Nojima Y, Nakata M (2015) Preoperative neutrophil/lymphocyte ratio and prognostic nutritional index predict survival in patients with non-small cell lung cancer. World J Surg Oncol 13:291CrossRef Shimizu K, Okita R, Saisho S, Maeda A, Nojima Y, Nakata M (2015) Preoperative neutrophil/lymphocyte ratio and prognostic nutritional index predict survival in patients with non-small cell lung cancer. World J Surg Oncol 13:291CrossRef
15.
Zurück zum Zitat Hong S, Zhou T, Fang W, Xue C, Hu Z, Qin T, Tang Y, Chen Y, Ma Y, Yang Y, Hou X, Huang Y, Zhao H, Zhao Y, Zhang L (2015) The prognostic nutritional index (PNI) predicts overall survival of small-cell lung cancer patients. Tumour Biol 36:3389–3397CrossRef Hong S, Zhou T, Fang W, Xue C, Hu Z, Qin T, Tang Y, Chen Y, Ma Y, Yang Y, Hou X, Huang Y, Zhao H, Zhao Y, Zhang L (2015) The prognostic nutritional index (PNI) predicts overall survival of small-cell lung cancer patients. Tumour Biol 36:3389–3397CrossRef
16.
Zurück zum Zitat Go SI, Jeon H, Park SW, Kang MH, Kim HG, Lee GW (2018) Low pre-treatment nutritional index is significantly related to poor outcomes in small cell lung cancer. Thorac Cancer 9(11):1483–1491CrossRef Go SI, Jeon H, Park SW, Kang MH, Kim HG, Lee GW (2018) Low pre-treatment nutritional index is significantly related to poor outcomes in small cell lung cancer. Thorac Cancer 9(11):1483–1491CrossRef
17.
Zurück zum Zitat Jin S, Cao S, Xu S, Wang C, Meng Q, Yu Y (2018) Clinical impact of pretreatment prognostic nutritional index (PNI) in small cell lung cancer patients treated with platinum-based chemotherapy. Clin Respir J 12:2433–2440CrossRef Jin S, Cao S, Xu S, Wang C, Meng Q, Yu Y (2018) Clinical impact of pretreatment prognostic nutritional index (PNI) in small cell lung cancer patients treated with platinum-based chemotherapy. Clin Respir J 12:2433–2440CrossRef
18.
Zurück zum Zitat Shoji F, Morodomi Y, Akamine T, Takamori S, Katsura M, Takada K, Suzuki Y, Fujishita T, Okamoto T, Maehara Y (2016) Predictive impact for postoperative recurrence using the preoperative prognostic nutritional index in pathological stage I non-small cell lung cancer. Lung Cancer 98:15–21CrossRef Shoji F, Morodomi Y, Akamine T, Takamori S, Katsura M, Takada K, Suzuki Y, Fujishita T, Okamoto T, Maehara Y (2016) Predictive impact for postoperative recurrence using the preoperative prognostic nutritional index in pathological stage I non-small cell lung cancer. Lung Cancer 98:15–21CrossRef
19.
Zurück zum Zitat Jian-Hui C, Iskandar EA, Cai S et al (2016) Significance of Onodera’s prognostic nutritional index in patients with colorectal cancer: a large cohort study in a single Chinese institution. Tumour Biol 37:3277–3283CrossRef Jian-Hui C, Iskandar EA, Cai S et al (2016) Significance of Onodera’s prognostic nutritional index in patients with colorectal cancer: a large cohort study in a single Chinese institution. Tumour Biol 37:3277–3283CrossRef
20.
Zurück zum Zitat Roxburgh CS, McMillan DC (2010) Role of systemic inflammatory response in predicting survival in patients with primary operable cancer. Future Oncol 6:149–163CrossRef Roxburgh CS, McMillan DC (2010) Role of systemic inflammatory response in predicting survival in patients with primary operable cancer. Future Oncol 6:149–163CrossRef
21.
Zurück zum Zitat Hofbauer SL, Pantuck AJ, de Martino M et al (2015) The preoperative prognostic nutritional index is an independent predictor of survival in patients with renal cell carcinoma. Urol Oncol 33(2):68.e61–68.e67CrossRef Hofbauer SL, Pantuck AJ, de Martino M et al (2015) The preoperative prognostic nutritional index is an independent predictor of survival in patients with renal cell carcinoma. Urol Oncol 33(2):68.e61–68.e67CrossRef
22.
Zurück zum Zitat Ding JD, Yao K, Wang PF, Yan CX (2018) Clinical significance of prognostic nutritional index in patients with glioblastomas. Medicine (Baltimore) 97(48):e13218CrossRef Ding JD, Yao K, Wang PF, Yan CX (2018) Clinical significance of prognostic nutritional index in patients with glioblastomas. Medicine (Baltimore) 97(48):e13218CrossRef
23.
Zurück zum Zitat Wei GB, Lu YY, Liao RW, Chen QS, Zhang KQ (2016) Prognostic nutritional index predicts prognosis in patients with metastatic nasopharyngeal carcinoma. Onco Targets Ther 9:5955–5961CrossRef Wei GB, Lu YY, Liao RW, Chen QS, Zhang KQ (2016) Prognostic nutritional index predicts prognosis in patients with metastatic nasopharyngeal carcinoma. Onco Targets Ther 9:5955–5961CrossRef
24.
Zurück zum Zitat Park S, Park S, Lee SH, Suh B, Keam B, Kim TM, Kim DW, Kim YW, Heo DS (2016) Nutritional status in the era of target therapy : poor nutrition is a prognostic factor in non-small cell lung cancer with activating epidermal growth factor receptor mutati- ons. Korean J Intern Med 31(6):1140–1149CrossRef Park S, Park S, Lee SH, Suh B, Keam B, Kim TM, Kim DW, Kim YW, Heo DS (2016) Nutritional status in the era of target therapy : poor nutrition is a prognostic factor in non-small cell lung cancer with activating epidermal growth factor receptor mutati- ons. Korean J Intern Med 31(6):1140–1149CrossRef
25.
Zurück zum Zitat Xu WJ, Kang YM, Zhou L, Chen FF, Song YH, Zhang CQ (2017) Clinical application value of prognostic nutritional index for predicting survival in patients with advanced non-small cell lung cancer. Zhonghua Zhong Liu Za Zhi 39(2):146–149PubMed Xu WJ, Kang YM, Zhou L, Chen FF, Song YH, Zhang CQ (2017) Clinical application value of prognostic nutritional index for predicting survival in patients with advanced non-small cell lung cancer. Zhonghua Zhong Liu Za Zhi 39(2):146–149PubMed
26.
Zurück zum Zitat Sagawa M, Yoshimatsu K, Yokomizo H et al (2013) Assessment of host status in patients treated with mFOLFOX6 adjuvant chemotherapy after colorectal cancer surgery. Gan To Kagaku Ryoho 40:1587–1589PubMed Sagawa M, Yoshimatsu K, Yokomizo H et al (2013) Assessment of host status in patients treated with mFOLFOX6 adjuvant chemotherapy after colorectal cancer surgery. Gan To Kagaku Ryoho 40:1587–1589PubMed
27.
Zurück zum Zitat Miao Y, Li S, Yan Q, Li B, Feng Y (2016) Prognostic significance of preoperative prognostic nutritional index in epithelial ovarian CancerPatients treated with platinum-based chemotherapy. Oncol Res Treat 39(11):712–719CrossRef Miao Y, Li S, Yan Q, Li B, Feng Y (2016) Prognostic significance of preoperative prognostic nutritional index in epithelial ovarian CancerPatients treated with platinum-based chemotherapy. Oncol Res Treat 39(11):712–719CrossRef
28.
Zurück zum Zitat Nozoe T, Kohno M, Iguchi T, Mori E, Maeda T, Matsukuma A, Ezaki T (2012) The prognostic nutritional index can be a prognostic indicator in colorectal carcinoma. Surg Today 42(6):532–535CrossRef Nozoe T, Kohno M, Iguchi T, Mori E, Maeda T, Matsukuma A, Ezaki T (2012) The prognostic nutritional index can be a prognostic indicator in colorectal carcinoma. Surg Today 42(6):532–535CrossRef
29.
Zurück zum Zitat Maeda K, Shibutani M, Otani H, Nagahara H, Sugano K, Ikeya T, Kubo N, Amano R, Kimura K, Muguruma K, Tanaka H, Hirakawa K (2014) Low nutritional prognostic index correlates with poor survival in patients with stage IV colorectal cancer following palliative resection of the primary tumor. World J Surg 38(5):1217–1222CrossRef Maeda K, Shibutani M, Otani H, Nagahara H, Sugano K, Ikeya T, Kubo N, Amano R, Kimura K, Muguruma K, Tanaka H, Hirakawa K (2014) Low nutritional prognostic index correlates with poor survival in patients with stage IV colorectal cancer following palliative resection of the primary tumor. World J Surg 38(5):1217–1222CrossRef
30.
Zurück zum Zitat Hsieh MC, Rau KM, Chiang PH, Sung MT, Lan J, Luo HL, Huang CC, Huang CH, Su HYL (2018) Impact of prognostic nutritional index on overall survival for patients with metastatic UrothelialCarcinoma. J Cancer 9(14):2466–2471CrossRef Hsieh MC, Rau KM, Chiang PH, Sung MT, Lan J, Luo HL, Huang CC, Huang CH, Su HYL (2018) Impact of prognostic nutritional index on overall survival for patients with metastatic UrothelialCarcinoma. J Cancer 9(14):2466–2471CrossRef
31.
Zurück zum Zitat Watanabe M, Iwatsuki M, Iwagami S, Ishimoto T, Baba Y, Baba H (2012) Prognostic nutritional index predicts outcomes of gastrectomy in the elderly. World J Surg 36:1632–1639CrossRef Watanabe M, Iwatsuki M, Iwagami S, Ishimoto T, Baba Y, Baba H (2012) Prognostic nutritional index predicts outcomes of gastrectomy in the elderly. World J Surg 36:1632–1639CrossRef
32.
Zurück zum Zitat Broggi MS, Patil D, Baum Y, Nieh PT, Alemozaffar M, Pattaras JG, Ogan K, Master VA (2016) Onodera’s prognostic nutritional index as an independent prognostic factor in clear cell renal cell carcinoma. Urology 96:99–105CrossRef Broggi MS, Patil D, Baum Y, Nieh PT, Alemozaffar M, Pattaras JG, Ogan K, Master VA (2016) Onodera’s prognostic nutritional index as an independent prognostic factor in clear cell renal cell carcinoma. Urology 96:99–105CrossRef
33.
Zurück zum Zitat Sun K, Chen S, Xu J, Li G, He Y (2014) The prognostic significance of the prognostic nutritional index in cancer: a systematic review and meta-analysis. J Cancer Res Clin Oncol 140:1537–1549CrossRef Sun K, Chen S, Xu J, Li G, He Y (2014) The prognostic significance of the prognostic nutritional index in cancer: a systematic review and meta-analysis. J Cancer Res Clin Oncol 140:1537–1549CrossRef
Metadaten
Titel
Is the prognostic nutritional index a prognostic and predictive factor in metastatic non-small cell lung cancer patients treated with first-line chemotherapy?
verfasst von
Yakup Bozkaya
Osman Köstek
Abdullah Sakin
Deniz Tataroğlu Özyükseler
Teoman Şakalar
İbrahim Çil
Publikationsdatum
30.08.2019
Verlag
Springer Berlin Heidelberg
Erschienen in
Supportive Care in Cancer / Ausgabe 5/2020
Print ISSN: 0941-4355
Elektronische ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-019-05055-x

Weitere Artikel der Ausgabe 5/2020

Supportive Care in Cancer 5/2020 Zur Ausgabe

CUP-Syndrom: Künstliche Intelligenz kann Primärtumor finden

30.04.2024 Künstliche Intelligenz Nachrichten

Krebserkrankungen unbekannten Ursprungs (CUP) sind eine diagnostische Herausforderung. KI-Systeme können Pathologen dabei unterstützen, zytologische Bilder zu interpretieren, um den Primärtumor zu lokalisieren.

Sind Frauen die fähigeren Ärzte?

30.04.2024 Gendermedizin Nachrichten

Patienten, die von Ärztinnen behandelt werden, dürfen offenbar auf bessere Therapieergebnisse hoffen als Patienten von Ärzten. Besonders gilt das offenbar für weibliche Kranke, wie eine Studie zeigt.

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.